Professional Documents
Culture Documents
Dr. V. Swathi P
Definition
• The word ‘ichthyosis’ is derived from the Greek word
‘ichthys’, which means fish.
• Recently icthyosis has been classified as syndromic
and non‐syndromic in contrast, the onset of the
disease, namely the distinction between ‘congenital
onset’ and ‘non‐congenital onset’.
Non Syndromic Icthyosis
Common ichthyoses
• Ichthyosis vulgaris (IV)
• Non‐syndromic recessive X‐linked ichthyosis (RXLI)
Autosomal recessive congenital ichthyosis (ARCI)
• Harlequin ichthyosis (HI)
• Lamellar ichthyosis (LI)
• Congenital ichthyosiform erythroderma (CIE)
• Self‐healing collodion baby
• Acral self‐healing collodion baby
• Bathing suit ichthyosis (BSI)
Keratinopathic ichthyosis (KPI)
• Epidermolytic ichthyosis (EI)
• Superficial epidermolytic ichthyosis (SEI)
• Congenital reticular ichthyosiform erythroderma (CRIE)
• Annular epidermolytic ichthyosis (AEI)
• Ichthyosis Curth–Macklin (ICM)
• Epidermolytic naevi
Other non‐syndromic forms
• Loricrin keratoderma (LK)
• Erythrokeratodermia variabilis (EKV)
• Inflammatory peeling skin disease (PSS type B)
• Exfoliative ichthyosis AR Keratosis linearis–
ichthyosis congenita–keratoderma (KLICK)
Common ichtyosis
Icthyosis Vulgaris X-linked Icthyosis
Impaired
squamous cell
formation, TEWL,
Epidermal
and develop
defect:
inflammatory
responses on
exposure to
allergens and
haptens
Icthyosis Vulgaris X-linked
Icthyosis
Pathophysiology
• ABCA12 transfer lipids such as glucosylceramides, into
lamellar bodies.
• It also transport proteases such as kallikrein 5, 7, and 14
into lamellar bodies and secrete these proteins into the
intercellular space in the stratum corneum.
HPE: Hyperkeratosis, parakeratosis and hypergranulosis
Clinical Features:
• Very thick, yellow–brown plates
Palmar keratoderma
Congenital ichthyosiform erythroderma: Ectropion
Diffuse erythema and scaling
• Moreover, there is a group of patients who initially
present as collodion babies, progress to mild CIE and
later may present with a very mild or even absent
scaling.
• This phenotype is referred to as Self‐improving
congenital ichthyosis.
Self‐improving congenital ichthyosis.
• Neonates with lipoxygenase mutations are born with
a mild collodion and later present with the CIE
phenotype, although some also present brownish
scales.
• Typically, they show a striking palmoplantar
hyperlinearity which is reminiscent of the accentuated
creases in IV
Clinical phenotype of ALOXE3 mutations. Note palmoplantar
hyperlinearity resembling accentuated creases in ichthyosis
vulgaris
• However, mild keratotic lichenifications of the elbow
fossa or of the dorsum of the hands help to rule out this
differential diagnosis.
• Patients may progress to SICI
• Those with ALOX12B mutations more often exhibit
pronounced palmoplantar keratosis than patients with
ALOXE3 mutations
• Patients with NIPAL4 mutation often present with a
CIE/LI overlapping phenotype, ectropion, clubbing of
the nails and a pronounced and diffuse yellowish
keratoderma on the palms and soles
Clinical phenotype of NIPAL4
mutations. Diffuse yellowish
keratoderma on palms and soles.
Reticulate scaling on the trunk
• Patients with CYP4F2 mutations present with a CIE or
mild collodion baby phenotype at birth
• As the children grow older, they develop whitish‐grey
scales which are more pronounced in the periumbilical
region
• Palms and soles show pronounced hyperlinearity or even
PPK.
• Mutations in CERS3 - born as collodion babies,
progress to CIE, improvement of the ichthyosis in
summer.
• Marked plantar hyperlinearity, pruritus, recurrent
uncomplicated bacterial and Pityrosporum
infections.
Clinical phenotype of CERS3 deficiency. Mild plantar keratoderma
with hyperlinearity.
• LIPN mutations seem to cause a late‐onset form of
ichthyosis at the age of 5 years, so that it is not
formally a congenital ichthyosis, although it belongs
pathophysiologically to the ARCI spectrum
Investigation:
• Clinical;
• Electron microscopy; in situ transglutaminase-1
expression and activity assay;
• Molecular testing.
Bathing suit icthyosis
• Recombinant expression of the TGM1 mutations in BSI
showed that they exhibit a marked shift in temperature
optimum from 37°C to 31°C.
• Deficient activity of BSI mutants could be rescued and
even reconstituted by decreasing the temperature to below
33°C.
• All BSI mutations showed an activity above 10% at their
temperature optimum at 31°C and a dramatic decrease at
37°C
Clinical features
• Born as collodion babies
• Shedding of the collodion membrane is followed by the
development of large dark grey/brownish scales affecting
the trunk and the scalp, but sparing the face and
extremities.
• Palms and soles are dry and diffusely mildly
hyperkeratotic.
• Worse in the summer and improve in winter.
• Hypohydrosis as is often seen in ARCI may play a
crucial role in local heat accumulation that results in
additional reduction of TG1 activity
• Hyperkeratoses can develop in the ear canal affecting
the ability to hear.
Digital thermography validated a striking
correlation between warmer body areas and the
presence of scaling in patients
Management of congenital ichthyoses
• These neonates are taken care of in a neonatal intensive
care unit
• Collodion babies should be placed in a high humidity
incubator with close monitoring of body temperature.
• Recommended to start with humidity in range of 60–80%,
and to decrease every 3–4 days in order to reach normal
humidity conditions, so that the children can be
transferred to an open crib.
• Bland ointments, e.g. a dexpanthenol containing
ointment two to four times a day.
• Percutaneous absorption is very high and substances
typically used in older children with ichthyosis, such as
urea or lactic acid should be avoided in the first year of
life.
• Salicylic acid is contraindicated as it may result in
metabolic acidosis and death within 72 h even when
used in low concentrations such as 3%.
Issue of bathing
• There is beneficial effect of bathing for ARCI and KPI
and in particular with bath additives such as sodium
bicarbonate
• It has been shown that two handfuls of baking soda to a
bath tub will raise the pH from 5.5 to 7.9
• Ocean water that many patients also report to be
beneficial usually has a pH above 8.1
• It is conceivable that mild alkalinization of the skin
raises the pH to an optimum for serine protease
activity such as KLK5 and KLK7
• Other popular bath additives are wheat corn or rice
starch or bran, e.g. in Netherton syndrome.
• Antiseptics as bath additives can become necessary,
e.g. in KPI, to overcome bad odour.
• Oils are usually messy and not recommended.
Practical treatment options for daily care
• Patients with ARCI or KPI generally need to bath at
least once a day.
• After soaking the skin for around 20–30 min, the patient
or a parent can use a sponge, microfibre cloth or silk
glove to rub the skin and thus provide mechanical scale
removal as well as cleansing (i.e. removal of remaining
ointment).
• This again may take another 20–30 min.
• Drying with a towel and the immediate application of
ointments should be done while the skin is still wet.
• A variety of topical ointments can be used but local
availability as well as composition will depend on the
country and its traditions.
• Urea‐based ointments (up to 10%) and lactic acid
based ointments (up to 12%) as well as glycerol
based ointments are widely used.
• Substances such as macrogol 400 or propylene
glycol can decrease the scaling and work as
keratolytics.
• Tazarotene gel has been recommended for the treatment
and prevention of ectropion.
• N‐acetylcysteine blocks cell‐cycle progression in the G1
phase and has an antiproliferative effect.
Systemic treatment options
• LI – require rigorous treatment and usually benefit from
systemic retinoids as well as from urea or lactic acid
containing ointments.
• CIE may respond less well to systemic retinoids – some
even can get worse – and also they tolerate moisturizers
such as lactic acid or urea less well.
• EKV is known to respond rapidly to low‐dose treatment
with retinoids
• In patients with HI, the use of retinoids is warranted,
even in newborns
• Patients suffering from EI due to KRT1 mutations have a
strong risk of exacerbation of the disease when given
retinoids, while those with KRT10 mutations may benefit
when given a low dosage, e.g. up to 0.5 mg/kg body
weight.
• Superficial EI responds well to low retinoid doses
• Patients with ichthyosis may be treated when they are
over the age of 16 or who have stopped growing
significantly.
• In women of child‐bearing age, isotretinoin prefered over
acetretin
• ‘Drug holidays’ are popular in particular when using
isotretinoin.
• A side effect of alitretinoin therapy may be
hypothyroidism that can cause tiredness and it seems
to be advisable to monitor thyroid stimulating
hormone (TSH) levels in these patients
Special aspects of treatment
Eye.
• Surgical corrective treatment of chronic ectropion
• Camisa syndrome
Pathophysiology
• Mutations in the LOR gene encoding loricrin, a glycine‐
rich cornified envelope protein.
• The mutant protein interfere with the regulation of
cornification.
Clinical features.
• Collodion babies
• Ichthyosis is generally mild and may pass unnoticed.